Arcturus Therapeutics Holdings Inc. (ARCT) Form 10-Q Quarterly Reports
Arcturus Therapeutics Holdings Inc. (ARCT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARCT
CIK: 1768224
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerKC Freer
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001623632-26-001546 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-23 | 8-K Filing | 0001193805-26-001277 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-25 | 8-K Filing | 0001193805-26-001130 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338090 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K Filing | 0001193805-26-001039 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-26 | 8-K Filing | 0001193805-26-000910 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-05 | 4 Filing | 0001193805-26-000829 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-05 | 4 Filing | 0001193805-26-000828 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-05 | 4 Filing | 0001193805-26-000827 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-05 | 4 Filing | 0001193805-26-000826 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-05 | 4 Filing | 0001193805-26-000825 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-05 | 4 Filing | 0001193805-26-000824 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-05 | 4 Filing | 0001193805-26-000823 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-05 | 8-K Filing | 0001193805-26-000770 | View SEC Doc Filr Page |
| 4 | 2026-05-07 | 2026-05-01 | 4 Filing | 0001193805-26-000578 | View SEC Doc Filr Page |
| 3 | 2026-05-07 | 2026-05-01 | 3 Filing | 0001193805-26-000577 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001193125-26-211943 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-01 | 8-K Filing | 0001193805-26-000573 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-07 | — | SCHEDULE 13G/A Filing | 0001104659-26-057041 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2026-06-05 | DEF 14A Filing | 0001193805-26-000507 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-26 | — | SCHEDULE 13G/A Filing | 0000102909-26-000697 | View SEC Doc Filr Page |
| 10-K | 2026-03-03 | 2025-12-31 | 10-K | 0001193125-26-088391 | View SEC Doc Filr Page |
| 8-K | 2026-03-03 | 2026-03-03 | 8-K Filing | 0001193805-26-000214 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0001193125-26-052923 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-03 | — | SCHEDULE 13G/A Filing | 0001104659-26-009576 | View SEC Doc Filr Page |